Prof. Raphael Gorodetsky | Hadassah International

Pluristem Stem Cell therapy, Based on Hadassah Preclinical Research, Has Been Cleared by FDA to Treat Acute Radiation Syndrome

Pluristem Therapeutics has announced that its new cell therapy to treat acute radiation syndrome (PLX-R18), based on the pioneering studies performed within the laboratory of Prof. Raphael Gorodetsky at the…

Facebook

Twitter

Placenta-based Cell Therapy

Placental Stem Cell Therapy to Treat Acute Radiation Syndrome Receives Boost from FDA

Placenta-based Cell Therapy

Placental Cells Found to Have Potential to Mitigate Acute Radiation Syndrome

Bone-marrow (transplantation)

Hadassah International

Pluristem Stem Cell therapy, Based on Hadassah Preclinical Research, Has Been Cleared by FDA to Treat Acute Radiation Syndrome

Pluristem Stem Cell therapy, Based on Hadassah Preclinical Research, Has Been Cleared by FDA to Treat Acute Radiation Syndrome

Placental Stem Cell Therapy to Treat Acute Radiation Syndrome Receives Boost from FDA

Placental Cells Found to Have Potential to Mitigate Acute Radiation Syndrome

Hadassah-Pluristem Trial Approved for Placental Cell Bone Marrow Regeneration